How to buy Nephros stock | $6.64

Nephros, Inc is a medical instruments & supplies business based in the US. Nephros shares (NEPH) are listed on the NASDAQ and all prices are listed in US Dollars. Nephros employs 25 staff and has a trailing 12-month revenue of around USD$9.4 million.

How to buy shares in Nephros

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Nephros. Find the stock by name or ticker symbol: NEPH. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nephros reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$6.64, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Nephros, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Nephros. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Nephros share price

Use our graph to track the performance of NEPH stocks over time.

Nephros shares at a glance

• Key figures

Information last updated 2020-12-04.

Latest market close	USD$6.64
52-week range	USD$4.42 - USD$10.4018
50-day moving average	USD$6.2991
200-day moving average	USD$7.1696
Wall St. target price	USD$12.92
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.518

Buy Nephros shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Nephros stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Nephros, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nephros price performance over time

Historical closes compared with the close of $6.64 from 2020-12-09

1 week (2021-01-11)	-14.87%
1 month (2020-12-22)	-13.32%
3 months (2020-10-18)	N/A
6 months (2020-07-18)	N/A

1 year (2020-01-18)	N/A
2 years (2019-01-18)	1,006.67%
3 years (2018-01-18)	1,283.33%
5 years (2016-01-18)	N/A

Nephros financials

Revenue TTM	USD$9.4 million
Gross profit TTM	USD$6.1 million
Return on assets TTM	-19.22%
Return on equity TTM	-43.07%
Profit margin	-44.22%
Book value	$0.928
Market capitalisation	USD$61.6 million

TTM: trailing 12 months

Shorting Nephros shares

There are currently 7,139 Nephros shares held short by investors – that's known as Nephros's "short interest". This figure is 65.3% down from 20,563 last month.

There are a few different ways that this level of interest in shorting Nephros shares can be evaluated.

Nephros's "short interest ratio" (SIR)

Nephros's "short interest ratio" (SIR) is the quantity of Nephros shares currently shorted divided by the average quantity of Nephros shares traded daily (recently around 6999.0196078431). Nephros's SIR currently stands at 1.02. In other words for every 100,000 Nephros shares traded daily on the market, roughly 1020 shares are currently held short.

However Nephros's short interest can also be evaluated against the total number of Nephros shares, or, against the total number of tradable Nephros shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nephros's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Nephros shares in existence, roughly 0 shares are currently held short) or 0.0012% of the tradable shares (for every 100,000 tradable Nephros shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Nephros.

Find out more about how you can short Nephros stock.

Nephros share dividends

We're not expecting Nephros to pay a dividend over the next 12 months.

Have Nephros's shares ever split?

Nephros's shares were split on a 1:9 basis on 10 July 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nephros shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Nephros shares which in turn could have impacted Nephros's share price.

Nephros share price volatility

Over the last 12 months, Nephros's shares have ranged in value from as little as $4.42 up to $10.4018. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nephros's is 0.9144. This would suggest that Nephros's shares are less volatile than average (for this exchange).

Nephros overview

Nephros, Inc., a commercial-stage company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems in the United States. It operates through two segments, Water Filtration and Renal Products. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; hemodiafilters for use as dialyzers in hemodialysis treatment; and water filters to health care, food service, hospitality, and convenience store markets under the AETHER brand name. The company was founded in 1997 and is headquartered in South Orange, New Jersey.

Frequently asked questions

• What percentage of Nephros is owned by insiders or institutions?

  Currently 11.97% of Nephros shares are held by insiders and 53.08% by institutions.

• How many people work for Nephros?

  Latest data suggests 25 work at Nephros.

• When does the fiscal year end for Nephros?

  Nephros's fiscal year ends in December.

• Where is Nephros based?

  Nephros's address is: 380 Lackawanna Place, South Orange, NJ, United States, 07079

• What is Nephros's ISIN number?

  Nephros's international securities identification number is: US6406714005

• What is Nephros's CUSIP number?

  Nephros's Committee on Uniform Securities Identification Procedures number is: 640671103